Aerie Pharmaceuticals - OIS@ASCRS 2015

preview_player
Показать описание
Rhopressa is a Rho-kinase and norepinephrine transporter inhibitor and lowers episcleral venous pressure, with phase 3 efficacy data expected mid-Q2 2015, and an FDA filing in mid-2016.

For more in Ophthalmology innovation visit:
Рекомендации по теме
welcome to shbcf.ru